A complaint filed on behalf of a Florida woman who allegedly suffered liver failure after taking Tylenol has been transferred to federal court. The product liability lawsuit, which was filed in Florida state court in February, was removed by Johnson & Johnson (J&J) to the U.S. District Court for the Middle District of Florida late last month. J&J reportedly transferred the case based on diversity of citizenship between the company and the plaintiff.
What’s the problem?
June 5, 2012 – According to allegations raised in the complaint, Charlotte Lee Thompson suffered liver failure in February 2008, after taking Tylenol for a number of days. Although Thompson claims she took the drug according to the recommended dosages, she believes her injuries were caused by complications of the acetaminophen contained in Tylenol. Thompson was subsequently hospitalized and remained in intensive care for nearly two weeks with liver failure from Tylenol, according to the complaint.
The U.S. Food & Drug Administration (FDA) has published statistics indicating that acetaminophen overdoses are a leading cause of liver failure in the United States. Each year, the drug is linked to more than:
- 50,000 emergency room visits;
- 25,000 hospitalizations;
- 450 deaths.
Over the past several years, a growing number of Tylenol liver failure lawsuits have been filed in courthouses around the country on behalf of individuals who allege that the drug contains inadequate warnings, and that J&J failed to inform the public about the risk of liver failure. Thompson is accusing J&J of:
- manufacturing, marketing and distributing a defective product;
- failure to warn;
- breach of warranty.
She is seeking compensation for:
- medical expenses;
- economic losses;
- physical and emotional injuries;
- punitive damages.